GH Research Plc (GHRS)
20.44
+1.28
(+6.68%)
USD |
NASDAQ |
Apr 30, 16:00
20.44
0.00 (0.00%)
After-Hours: 20:00
GH Research Shareholders Equity (Quarterly) : 279.70M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 332.33M |
| Compass Pathways Plc | -52.85M |
| Atai Beckley, Inc. | 221.87M |
| Jazz Pharmaceuticals Plc | 4.319B |
| Nektar Therapeutics | 89.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.23M |
| Total Liabilities (Quarterly) | 8.527M |
| Debt to Equity Ratio | 0.0018 |
| Current Ratio | 34.13 |
| Net Debt Paydown Yield | 0.01% |